Muhammad Talha Rehman Sherani

Muhammad Talha Rehman Sherani

Auto-generated profile, based on publicly available information

Muhammad Talha Rehman Sherani

Sandeman Provincial Hospital Quetta Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Clinical Case Reports
Verified
Journal Article
Open access
FBFazeela Bibi
Fazeela Bibi
ASAhmad Sanan
Ahmad Sanan
MHMuhammad Hamza
Muhammad Hamza
MSMuhammad Talha Rehman Sherani
Muhammad Talha Rehman Sherani
SSSultan Salahuddin
Sultan Salahuddin
SSSaid Hamid Sadat
Said Hamid Sadat
Platelet‐rich plasma (PRP) therapy, while widely utilized for its favorable safety profile, carries a recognized risk of catastrophic, irreversible vision loss, traditionally attributed to iatrogenic vascular embolization following facial injections. We present the first documented case of reversible , subacute vision loss following PRP injections to the scalp , a finding that fundamentally challenges this established paradigm. A 22‐year‐old female presented with unilateral central scotomas one month post‐treatment, with investigations revealing macular edema and an incidental, non‐compressive pituitary microadenoma. In contrast to direct embolic occlusion, we postulate a novel pathophysiological mechanism: a systemic surge of PRP‐derived growth factors (e.g., VEGF, PDGF) triggered a transient, steroid‐responsive inflammatory or microvascular event in a pre‐sensitized neurovascular environment. The patient achieved complete visual recovery following high‐dose corticosteroid therapy, supporting an inflammatory etiology. This case serves as an unequivocal clinical directive that the risk of severe ocular complications from PRP is not confined to facial injections and can manifest systemically. It is imperative that the paradigm of PRP‐related risk be expanded and informed consent protocols revised to reflect the potential for inflammatory and microvascular sequelae, irrespective of the injection site.

24 March 2025
Verified
Preprint
Open access
FBFazeela Bibi
Fazeela Bibi
ASAhmad Sanan
Ahmad Sanan
MHMuhammad Hamza
Muhammad Hamza
MRMuhammad Talha Rehman
Muhammad Talha Rehman
SSSultan Salahuddin
Sultan Salahuddin
SSSaid Hamid Sadat
Said Hamid Sadat